HTR1A and Huntington disease: Previous studies found that a single HD patient treated with perospirone, which acts as an antagonist for the 5-HT2A receptor and an agonist for the 5-HT1A receptor, showed significant control over involuntary movements and psychiatric symptoms [161], providing new avenues for future HD treatment research.